2.40k followers • 28 symbols Watchlist by Yahoo Finance
Follow this list to discover and track stocks that have been overbought as indicated by the RSI momentum indicator within the last week. A stock is overbought when the RSI is above 70. This list is generated daily, ranked based on market cap and limited to the top 30 stocks that meet the criteria.
ABT or BSX: Which Is a More Attractive Pick in April?(Continued from Prior Part)Revenue guidance In its first-quarter earnings conference call, Abbott Laboratories (ABT) reiterated its YoY organic sales growth rate of 6.5%–7.5% for fiscal 2019.
On Vertex's (VRTX) first-quarter earnings call, investor focus will be on its latest CF drug Symdeko's sales figure as well as the update on its CF triple-pill regimes.
While Pfizer's (PFE) key drugs like Ibrance and Xeljanz are likely to drive Q1 sales, genericization of key drugs and weak sales in the EH segment will hurt.
Eli Lilly and Company's (LLY) new drugs like Trulicity, Taltz and Jardiance are performing well. Let's see if these along with its older products lead to an earnings beat for the company in Q1.
ABT or BSX: Which Is a More Attractive Pick in April?(Continued from Prior Part)Abbott’s performance in the first quarter Abbott Laboratories (ABT) released its first-quarter earnings on April 17. The company reported revenues of $7.54 billion, a
The global demand for healthcare products and services will keep growing significantly. Here's your complete guide to finding the best healthcare stocks and ETFs.
ABT or BSX: Which Is a More Attractive Pick in April?Stock price movements On April 18, Abbott Laboratories (ABT) closed at $73.92, 1.43% higher than its previous closing price, 30.12% higher than its 52-week low of $56.81, and 8.45% below its
Domino's Pizza DPZ — Shares of Domino's Pizza climbed 4.9% on stronger-than-forecast quarterly earnings. Anadarko Petroleum APC — The energy company's stock jumped 11.6% after Occidental Petroleum announced a bid of $76 a share for Anadarko, topping an earlier offer from Chevron. Occidental's bid values Anadarko at $57 billion .
Anthem, which operates Blue Cross Blue Shield plans in 14 states, is facing a changed health insurance landscape after separate deals by rivals Aetna and Cigna Corp to merge with the biggest U.S. pharmacy benefits managers (PBMs) last year. Most members will be moved to Anthem's IngenioRx in the second half of the year and members from the company's government business will transition in 2020, Chief Financial Officer John Gallina said on a conference call with analysts. The Trump administration in January proposed a rule that, if enacted, would require Medicare Part D prescription plans and Medicare Advantage health plans to pass on these after-market rebates to patients.
During Trevena's (TRVN) first-quarter 2019 conference call, investor focus will be on the company's progress to support its development of the pain therapy ??? oliceridine injection.
Biogen (BIIB) beats estimates for both earnings and sales in the first quarter fueled mainly by strong performance of its muscle disease drug, Spinraza in international markets.